The Australian and New Zealand Vasculitis Society (ANZVASC) is a collaborative organisation of physicians, scientists, and communities that focuses on research, education, and clinical practices in vasculitis.
ANZVASC aims to:
- Advance research into the causes, management, and effective treatment of vasculitis.
- Establish and oversee a clinical care registry.
- Organise a network of clinical centres that are interested in taking part in research.
- Promote excellent clinical care for vasculitis patients.
- Support consumer and patient groups of vasculitis in Australia and New Zealand.
- Foster and encourage training in both clinical care and research in vasculitis.
- Coordinate meetings, seminars, and lectures in vasculitis.
- Liaise and cooperate with national and international vasculitis organisations.
- Increase public awareness of vasculitis.
- Advocate for the best care for vasculitis patients.
About the Board
Prof Richard Kitching
Chairman (MBChB) (Distinction) FRACP, PhD.
His research is focussed on autoimmune kidney disease – particularly vasculitis as the kidney is a critical target, from basic mechanisms of loss of tolerance to how the immune system injures tissues, with a view to using more targeted therapies for vasculitis.
In addition to his role in ANZVASC, he is Co-Chair of the ANZ Society of Nephrology Research Advisory Committee and Co-Chair of the Monash Partners Infection and Immunity Theme. His research is funded largely by the National Health and Medical Research Council.
He has published over 150 peer reviewed articles, many in vasculitis, including papers in Nature, Nature Medicine, Nature Communications, The Proceedings of the National Academy of Sciences USA, The Journal of Experimental Medicine, Blood, Kidney International, The Journal of the American Society of Nephrology and Arthritis and Rheumatology.
Prof Catherine Hill
Director (MBBS, MD, MSc) FRACP (MBChB)
Professor Catherine Hill is a clinical rheumatologist and epidemiologist with clinical training in Adelaide and postgraduate epidemiological and biostatistics training at Boston University. She works as a clinical rheumatologist at The Queen Elizabeth and Royal Adelaide Hospitals and Clinical Professor at University of Adelaide.
Her current research interests include vasculitis particularly Giant cell arteritis, intervention studies in osteoarthritis, population-based musculoskeletal epidemiology. She founded the SA Giant Cell Arteritis Registry in 2009. She is a Chief Investigator of North West Adelaide Health Study; a longitudinal population-based cohort study.
In addition, she is Chair of the Steering Committee of the Australian Rheumatology Association Database (ARAD) and is current Vice-President of the Australian Rheumatology Association.
She participates in drug regulatory work at both local, state and federal levels and is a member of the Pharmaceutical Benefits Advisory Committee and Chair of the South Australian Medicines Evaluation Panel. She co-chairs the OMERACT Glucocorticoid Impact SIG and Polymyalgia Rheumatica SIG, as well as membership of the OMERACT Technical Advisory Group.
Director (B.Sc, M.Sc (Biotech), Grad Dip Clin Micro, MBA)
Mark Street is the patient representative of ANZVASC. Mark is currently an Airline Pilot for a major Australian Airline. He previously held senior scientific roles with various Australian research and commercial companies. Mark holds a Masters in Science (Biotechnology), and is currently studying towards a Doctor of Medicine degree.
He is the founder of a number of both scientific and non-scientific companies.
Associate Professor Chen Au Peh
Director MBBS FRACP PhD
Chen Au Peh is a Renal Physician at the Royal Adelaide Hospital. He has had a long-standing commitment to improve the care of patients with ANCA-Associated Vasculitis. For many years, he has worked closely with international colleagues to conduct clinical trials for patients with vasculitis such as the RITUXVAS trial and the PEXIVAS trial. Evidence from these clinical trials has given rise to new therapeutic options for our patients.
Dr Daman Langguth
Treasurer (MBChB) FRACP, FRCPA.
Dr Daman Langguth is Director of Immunology at Sullivan Nicolaides Pathology and Clinical Immunologist at the Wesley Hospital.
His clinical interests are in Vasculitis, Myositis, IgG4 disease, and autoimmune blistering skin diseases as well as other complex autoimmune disease.
His laboratory interests are in neuro-immunology, sIGE development for Australian seafood and in therapeutic drug monitoring of auto-immune disease.
Dr Langguth’ s research interests are in identification of novel auto-antibodies in a variety of diseases, flow cytometric assessment of NETosis and immune function in ECMO, and in IF imaging analysis.
Dr Langguth is the chair of BPPQ of RCPA and was chair of recent MBS immunopathology review.
Prof Lisa Stamp
Director (MBChB, PhD) FRACP
Professor Stamp is a Rheumatologist at the University of Otago, Christchurch and Christchurch Public Hospital. Lisa completed her rheumatology training in New Zealand and Adelaide and her PhD at the University of Adelaide in Australia. She is Director of the Canterbury Rheumatology Immunology Research Group.
Her research interests include individualisation of drug treatments in rheumatic conditions, particularly gout and rheumatoid arthritis and epidemiology and treatment of vasculitis. She is the recipient of The Arthritis New Zealand National Researcher Award and the Gold Medal for Research by the University of Otago, Christchurch.
Dr Jessica Ryan
Director (MBBS, PhD) FRACP
Dr Jessica Ryan is a nephrologist and works in the busy Department of Nephrology at Monash Medical Centre, Clayton Victoria and is a senior lecturer at Monash University. Jessica completed a medical degree at Monash University and then a PhD that focused on the role of Spleen Tyrosine Kinase in autoimmune kidney disease.
She is involved in several nephrology inpatient and outpatient services including glomerulonephritis, renal genetics, and the Monash Renal Transplant service.
Jessica is also one of the clinicians who attends the Monash Vasculitis Clinic, which is a multidisciplinary clinic dedicated to the care of patients with vasculitis.
Dr Andrew McLean-Tooke
Director BSc MBChB, MD, FRCP, FCRPath, FRACP, FCRPA
Andrew graduated from Edinburgh University and trained in Clinical Immunology and Immunopathology at the Royal Victoria Infirmary in Newcastle-Upon-Tyne where he also completed an MD at Newcastle-Upon-Tyne University.
Having spent some time in Perth during his training he took up a consultant position in Perth and is currently the Head of Department of the Immunology Laboratory for PathWest QEII network and a Consultant at Sir Charles Gairdner Hospital and Perth Childrens Hospital. Andrews practice provides comprehensive clinical and diagnostic service in all aspects of clinical immunology including allergic disease, autoimmunity and immunodeficiency.
Andrews interests focus primarily on autoimmunity with focus on vasculitis, and primary immunodeficiency.